VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $105,756 | -10.6% | 3,930 | 0.0% | 0.07% | -6.9% |
Q2 2023 | $118,332 | -6.9% | 3,930 | 0.0% | 0.07% | -12.2% |
Q1 2023 | $127,136 | +12.9% | 3,930 | 0.0% | 0.08% | +5.1% |
Q4 2022 | $112,634 | +18.8% | 3,930 | 0.0% | 0.08% | +8.3% |
Q3 2022 | $94,792 | -11.9% | 3,930 | 0.0% | 0.07% | -6.5% |
Q2 2022 | $107,603 | -28.7% | 3,930 | 0.0% | 0.08% | -17.2% |
Q1 2022 | $151,000 | +19.8% | 3,930 | 0.0% | 0.09% | +22.4% |
Q4 2021 | $126,000 | +8.6% | 3,930 | 0.0% | 0.08% | -3.8% |
Q3 2021 | $116,000 | -13.4% | 3,930 | 0.0% | 0.08% | -13.2% |
Q2 2021 | $134,000 | +4.7% | 3,930 | 0.0% | 0.09% | -3.2% |
Q1 2021 | $128,000 | -9.9% | 3,930 | 0.0% | 0.09% | -13.0% |
Q4 2020 | $142,000 | -7.8% | 3,930 | 0.0% | 0.11% | -19.4% |
Q3 2020 | $154,000 | +6.9% | 3,930 | 0.0% | 0.13% | -0.7% |
Q2 2020 | $144,000 | +38.5% | 3,930 | -13.1% | 0.14% | +12.5% |
Q1 2020 | $104,000 | -21.2% | 4,525 | 0.0% | 0.12% | -7.0% |
Q4 2019 | $132,000 | – | 4,525 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |